Abstract
The pharmacokinetics of 5-fluorouracil (5FU) following its administration via the hepatic artery in conjunction with biodegradable albumin microspheres and angiotensin II have been studied. Peripheral venous concentrations of 5FU are lower and plasma clearance values higher following intrahepatic arterial administration compared with a similar dose administered by intravenous infusion over both 2 h and 24 h. For the 2 h drug infusions, plasma 5FU concentrations following co-treatment with angiotensin II and microspheres via the hepatic artery were intermediate between those of arterial and venous infusions of 5FU alone. There was a trend towards the peak plasma drug concentrations and the area under the plasma concentration-time curve (AUC) being significantly lower following co-treatment with angiotensin II and microspheres compared with intra-arterial and intravenous infusions of 5FU over 24 h. Co-administration of 5FU, angiotensin II and microspheres via the hepatic artery may reduce drug exposure in the systemic compartment and therefore may increase the therapeutic ratio of 5FU administration via the hepatic artery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Christophidis N., Mihaly G., Vajda F., Louis W. Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma. Clin Chem. 1979 Jan;25(1):83–86. [PubMed] [Google Scholar]
- Goldberg J. A., Bradnam M. S., Kerr D. J., Haughton D. M., McKillop J. H., Bessent R. G., Willmott N., McArdle C. S., George W. D. Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun. 1987 Dec;8(12):1033–1046. doi: 10.1097/00006231-198712000-00013. [DOI] [PubMed] [Google Scholar]
- Goldberg J. A., Bradnam M. S., Kerr D. J., McKillop J. H., Bessent R. G., McArdle C. S., Willmott N., George W. D. Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. Nucl Med Commun. 1987 Dec;8(12):1025–1032. doi: 10.1097/00006231-198712000-00012. [DOI] [PubMed] [Google Scholar]
- Goldberg J. A., Kerr D. J., Willmott N., McKillop J. H., McArdle C. S. Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer. 1988 Feb;57(2):186–189. doi: 10.1038/bjc.1988.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gyves J. W., Ensminger W. D., VanHarken D., Niederhuber J., Stetson P., Walker S. Improved regional selectivity of hepatic arterial mitomycin by starch microspheres. Clin Pharmacol Ther. 1983 Aug;34(2):259–265. doi: 10.1038/clpt.1983.163. [DOI] [PubMed] [Google Scholar]
- Lee T. K., Sokoloski T. D., Royer G. P. Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science. 1981 Jul 10;213(4504):233–235. doi: 10.1126/science.6787705. [DOI] [PubMed] [Google Scholar]
- Malik S. T., Wrigley P. F. Intra-arterial hepatic chemotherapy for liver malignancy. BMJ. 1988 Aug 13;297(6646):434–435. doi: 10.1136/bmj.297.6646.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sasaki Y., Imaoka S., Hasegawa Y., Nakano S., Ishikawa O., Ohigashi H., Taniguchi K., Koyama H., Iwanaga T., Terasawa T. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer. 1985 Jan 15;55(2):311–316. doi: 10.1002/1097-0142(19850115)55:2<311::aid-cncr2820550202>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- Willmott N., Cummings J., Stuart J. F., Florence A. T. Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat. Biopharm Drug Dispos. 1985 Jan-Mar;6(1):91–104. doi: 10.1002/bdd.2510060111. [DOI] [PubMed] [Google Scholar]